| Pharmaceutical active ingredients: |
| Thyme |
| Available forms, composition and doses of Melrosum Hustensirup: |
| N / A |
| Melrosum Hustensirup medical category: |
| Human:Herbs and natural products |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A03AX - Other drugs for functional bowel disorders |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisCassella-Med |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Meloxicam | Meloxicam | Sanofi-Aventis |
| Meloxiwin | Meloxicam | Sanofi-Aventis |
| Melrosum | Thyme | Sanofi-Aventis; Cassella-Med |
| Melrosum Codein Hustensirup | Codeine Phosphate | Sanofi-Aventis; Cassella-Med |
| Melrosum Extra Sterk | Codeine Phosphate; Vegetable Extracts | Sanofi-Aventis |
| Melrosum Hustensirup N | Burnet Saxifrage; Grindelia; Primula Root; Rose Petals; Thyme | Sanofi-Aventis |
| Melrosum Inhalationstropfen | Eucalyptus Oil; Pine Sylvestris Oil | Sanofi-Aventis; Cassella-Med |
| Melrosum Medizinalbad | Pine Sylvestris Oil; Thyme Oil | Sanofi-Aventis; Cassella-Med |
| Memoserina S | DL-Phosphoserine; Glutamine; Protein Hydrolysate; Vitamin B12 (Cyanocobalamin) | Sanofi-Aventis |
| Menactra | Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group A; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group C; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group W 135; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group Y | Sanofi-Aventis; Zuellig Pharma |